Showing 6,741 - 6,760 results of 63,539 for search '(( 2 e decrease ) OR ( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.33s Refine Results
  1. 6741

    Dephosphorylation of AMPK by PP2A phosphatase promotes neuritogenic effect of SIM in SH-SY5Y cells. by Varshiesh Raina (457377)

    Published 2013
    “…Simultaneously, inhibition of PP2A activity by Fostriecin showed increase in pAMPK (Thr-172) levels in presence or absence of SIM at 6 hrs <b>E</b>) Morphology of SH-SY5Y cells at 10 X magnification under light microscope showing significant (<i>p</i> < 0.001) decline in neuritogenic effect of SIM in presence of Fostriecin and an AMP analogue i.e. …”
  2. 6742
  3. 6743
  4. 6744
  5. 6745
  6. 6746
  7. 6747
  8. 6748
  9. 6749
  10. 6750
  11. 6751
  12. 6752
  13. 6753
  14. 6754

    Amplex Red H<sub>2</sub>O<sub>2</sub> measurements in <i>E</i>. <i>faecalis</i>-fed worms. by Saida Benomar (561001)

    Published 2020
    “…(C) RNAi downregulation of <i>bli-3</i> does not further decrease H<sub>2</sub>O<sub>2</sub> production in <i>E</i>. …”
  15. 6755
  16. 6756

    S1 Data - by Frank Thomas Mlingi (19852242)

    Published 2024
    “…Compressing the natural photoperiod caused a clear increase and decrease in GSI, T, 11-KT and E2 towards and during the spawning period. …”
  17. 6757

    Underlying data for the tables. by Huaji Jiang (16907514)

    Published 2025
    “…Here, we explore the role and precise mechanism of Van-Gogh-like 2 (VANGL2) during the pathogenesis of IBD. VANGL2 decreases in IBD patients and dextran sulfate sodium (DSS)-induced colitis in mice. …”
  18. 6758

    Image_1_Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules.pdf by Ward Vleeshouwers (10133363)

    Published 2021
    “…<p>Prostaglandin E2 (PGE2) is a lipid mediator that modulates the function of myeloid immune cells such as macrophages and dendritic cells (DCs) through the activation of the G protein-coupled receptors EP2 and EP4. …”
  19. 6759

    Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3‑Kinase (PI3K) by Marcian E. Van Dort (2562778)

    Published 2016
    “…Concurrent MEK1 and PI3K inhibition was demonstrated with inhibitors <b>9</b> and <b>14</b> in two tumor cell lines (A549, D54). Inhibitors produced dose-dependent decreased cell viability similar to the combined administration of equivalent doses of ZSTK474 and PD0325901. …”
  20. 6760